Pioneering technology inactivates SARS-CoV-2 virus and tuberculosis bacteria



[ad_1]

In a minute, [a tecnologia AT MicroProtect] managed to reach 100% inactivation of bacteria that cause tuberculosis disease in three of the four variants of the technology that were developed, ”the coordinator of the research, João Nunes, told Lusa today.

Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis complex, a dangerous bacteria that is also transmitted from person to person through zone.

“The airborne transmission of microorganisms, be they viruses or bacteria, is one of the most dangerous and difficult routes to control”, underlines João Nunes, arguing that “it is urgent to develop technology and effective solutions, but also capable of being implemented on a real scale and rapid response to implementation. “

New technology in the fight against COVID-19-19 IN MicroProtect It is also managed with the same technology to combat tuberculosis disease ”, says the researcher.

The innovative technique was created in âscope of a draft led by the BLC3 Technology and Innovation Campus, in Oliveira do Hospital, in the interior of the Coimbra district, in collaboration with the University of Minho and the Faculties of Pharmacy of the Universities of Lisbon and Coimbra.

“In one minute, 59,250 bacteria Mycobacterium tuberculosis, in three of the four variations of the technology developed it was possible to achieve 100% of inactivation and in the other variation, 98.75%, in tests done in triplicate “, explains João Nunes.

This is “a very important result and one that further demonstrates the potential” of AT MicroProtect.

Right now, he adds, “we are moving towards trials and tests with bacteria such as Legionella“which” also cause serious health problems, such as pneumonia. “

Soon, “there will be news in the context of the application of technology in real situations,” he predicts.

João Nunes also highlights that “a new level of knowledge has been reached at an international level about viruses and bacteria that cause infectious and airborne diseases, which will allow the development of new technologies.”

This new knowledge will allow to develop “a technology that works as a microbiological alarm in the detection levels of airborne contamination of viruses and bacteria above the level tolerateancia human “.

Its use can be within units, buildings and health systems. collective transportation, and other places where there are a large number of people, such as shopping malls and airports.

However, this research can only continue with the application of the results of the draft TO MicroProtectBecause, “to date, all the investment has been supported by the entities and researchers of the consortium involved in the work and that it will not be possible, at this stage, to advance with more developments,” he explains.

João Nunes also reveals that “it is also the motivation and mission of introducing AT technology in the market MicroProtect Create a microbiological laboratory with level 3 security in the Central region and for use in research and publicly, “which does not exist and is” a failure of the Central region, with a management model and capacity to have faster development responses ” . knowledgeable and effective in situations of pandemics, epidemics or outbreaks of microbiological contamination “.

This after testing and testing with AT technology has been supported MicroProtect be done in Spain and England, he concludes.

Always be the first to know.
Follow the chosen site for the fourth consecutive year Consumer Choice.
Download our free app.

Download Apple Store
Download from Google Play



[ad_2]